Literature DB >> 29170165

Philip Morris International introduces new heat-not-burn product, IQOS, in South Korea.

Minji Kim1.   

Abstract

Entities:  

Keywords:  advertising and promotion; packaging and labelling; tobacco industry

Mesh:

Year:  2017        PMID: 29170165      PMCID: PMC5966325          DOI: 10.1136/tobaccocontrol-2017-053965

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


× No keyword cloud information.
  6 in total

1.  The Pharmaceuticalization of the Tobacco Industry.

Authors:  Yogi Hale Hendlin; Jesse Elias; Pamela M Ling
Journal:  Ann Intern Med       Date:  2017-07-18       Impact factor: 25.391

2.  Comparing the cancer potencies of emissions from vapourised nicotine products including e-cigarettes with those of tobacco smoke.

Authors:  William E Stephens
Journal:  Tob Control       Date:  2017-08-04       Impact factor: 7.552

3.  Heat-Not-Burn Tobacco Cigarettes: Smoke by Any Other Name.

Authors:  Reto Auer; Nicolas Concha-Lozano; Isabelle Jacot-Sadowski; Jacques Cornuz; Aurélie Berthet
Journal:  JAMA Intern Med       Date:  2017-07-01       Impact factor: 21.873

4.  Industry watch: heat-not-burn tobacco products are about to reach their boiling point.

Authors:  Theodore L Caputi
Journal:  Tob Control       Date:  2016-08-24       Impact factor: 7.552

5.  Awareness and use of electronic cigarettes and heat-not-burn tobacco products in Japan.

Authors:  Takahiro Tabuchi; Kosuke Kiyohara; Takahiro Hoshino; Kanae Bekki; Yohei Inaba; Naoki Kunugita
Journal:  Addiction       Date:  2016-01-08       Impact factor: 6.526

6.  Assessing Health Impacts of Pictorial Health Warning Labels on Cigarette Packs in Korea Using DYNAMO-HIA.

Authors:  Eunjeong Kang
Journal:  J Prev Med Public Health       Date:  2017-06-25
  6 in total
  20 in total

1.  "It's Like Jogging Next to the Highway": A Qualitative Analysis of the Motivations and Experiences of Single-, Dual-, and Ex-Users of IQOS in The Netherlands.

Authors:  Anne Havermans; Lotte E van Nierop; Charlotte G G M Pauwels; Reinskje Talhout
Journal:  Toxics       Date:  2022-05-26

2.  PMI's heated tobacco products marketing claims of reduced risk and reduced exposure may entice youth to try and continue using these products.

Authors:  Karma McKelvey; Michael Baiocchi; Bonnie Halpern-Felsher
Journal:  Tob Control       Date:  2020-02-06       Impact factor: 7.552

3.  Analysis of FDA's IQOS marketing authorisation and its policy impacts.

Authors:  Lauren Kass Lempert; Stanton Glantz
Journal:  Tob Control       Date:  2020-06-29       Impact factor: 7.552

4.  Assessment of IQOS Marketing Strategies at Points-of-Sale in Israel at a Time of Regulatory Transition.

Authors:  Yael Bar-Zeev; Carla J Berg; Lorien C Abroms; Maya Rodnay; Daniel Elbaz; Amal Khayat; Hagai Levine
Journal:  Nicotine Tob Res       Date:  2022-01-01       Impact factor: 5.825

5.  'Do both': glo events and promotion in Germany.

Authors:  Kathleen Gali; Hannah Fuchs; Judith J Prochaska
Journal:  Tob Control       Date:  2021-01-21       Impact factor: 6.953

6.  Early adoption of heated tobacco products resembles that of e-cigarettes.

Authors:  Shu-Hong Zhu; Julian Ong; Shiushing Wong; Adam Cole; Yue-Lin Zhuang; Yuyan Shi
Journal:  Tob Control       Date:  2021-02-04       Impact factor: 6.953

7.  Awareness, experience and prevalence of heated tobacco product, IQOS, among young Korean adults.

Authors:  Jinyoung Kim; Hyunjae Yu; Sungkyu Lee; Yu-Jin Paek
Journal:  Tob Control       Date:  2018-08-29       Impact factor: 7.552

8.  Heated tobacco product regulation under US law and the FCTC.

Authors:  Lauren Kass Lempert; Stanton A Glantz
Journal:  Tob Control       Date:  2018-10-05       Impact factor: 7.552

9.  Revolution or redux? Assessing IQOS through a precursor product.

Authors:  Jesse Elias; Lauren M Dutra; Gideon St Helen; Pamela M Ling
Journal:  Tob Control       Date:  2018-10-10       Impact factor: 7.552

10.  Heated tobacco products: the example of IQOS.

Authors:  Stanton A Glantz
Journal:  Tob Control       Date:  2018-11       Impact factor: 7.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.